FDA hits Florida drugmakers with consent decree

Two Florida drug companies--Hill Dermaceuticals and Hill Labs--are now subject to an FDA consent decree prohibiting them from selling adulterated drugs across state lines. The agency went after the companies for "numerous deviations" from good manufacturing practices and for submitting falsified information, FDA said in a statement. Hill makes several topical prescription drugs and turns out two products on contract with Galderma. Release

Suggested Articles

The Trump administration has selected five COVID-19 vaccines for Operation Warp Speed, the NYT reports, with Big Pharma dominating the list.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

Bristol Myers Squibb's Zeposia will leverage promising top-line phase 3 data into a possible FDA approval in the lucrative ulcerative colitis market.